These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 22752771

  • 41. [Importance of the different i.v. iron generations for everyday medical practice].
    Biggar P, Hahn KM.
    MMW Fortschr Med; 2013 Mar 21; 155 Suppl 1():18-24. PubMed ID: 23678667
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron.
    Lichtenstein GR, Onken JE.
    Dig Dis Sci; 2018 Nov 21; 63(11):3009-3019. PubMed ID: 30056562
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women.
    Shim JY, Kim MY, Kim YJ, Lee Y, Lee JJ, Jun JK, Shin JC, Cho YK, Lee KY, Kim A, Song TB.
    BMC Pregnancy Childbirth; 2018 Aug 28; 18(1):349. PubMed ID: 30153811
    [Abstract] [Full Text] [Related]

  • 46. Parenteral iron sucrose in iron deficiency anaemia of paediatric chronic kidney disease.
    Moorani KN, Asim S.
    J Ayub Med Coll Abbottabad; 2011 Aug 28; 23(3):47-50. PubMed ID: 23272434
    [Abstract] [Full Text] [Related]

  • 47. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 Aug 28; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 48. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.
    Charytan C, Levin N, Al-Saloum M, Hafeez T, Gagnon S, Van Wyck DB.
    Am J Kidney Dis; 2001 Feb 28; 37(2):300-7. PubMed ID: 11157370
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia.
    Bregman DB, Morris D, Koch TA, He A, Goodnough LT.
    Am J Hematol; 2013 Feb 28; 88(2):97-101. PubMed ID: 23335357
    [Abstract] [Full Text] [Related]

  • 51. Role of Intravenous Ferric Carboxy-maltose in Pregnant Women with Iron Deficiency Anaemia.
    Mishra V, Gandhi K, Roy P, Hokabaj S, Shah KN.
    J Nepal Health Res Counc; 2017 Sep 08; 15(2):96-99. PubMed ID: 29016575
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Ferric carboxymaltose for the treatment of iron-deficiency anemia. [corrected].
    Muñoz M, Martín-Montañez E.
    Expert Opin Pharmacother; 2012 Apr 08; 13(6):907-21. PubMed ID: 22413903
    [Abstract] [Full Text] [Related]

  • 54. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O, Richard-Davis G, Morris T, Armstrong J.
    Clin Ther; 2007 Aug 08; 29(8):1682-91. PubMed ID: 17919549
    [Abstract] [Full Text] [Related]

  • 55. Comparative rates of adverse events with different formulations of intravenous iron.
    Okam MM, Mandell E, Hevelone N, Wentz R, Ross A, Abel GA.
    Am J Hematol; 2012 Nov 08; 87(11):E123-4. PubMed ID: 22965928
    [Abstract] [Full Text] [Related]

  • 56. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy.
    Khalafallah A, Dennis A, Bates J, Bates G, Robertson IK, Smith L, Ball MJ, Seaton D, Brain T, Rasko JE.
    J Intern Med; 2010 Sep 08; 268(3):286-95. PubMed ID: 20546462
    [Abstract] [Full Text] [Related]

  • 57. Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia*.
    Heming N, Lettéron P, Driss F, Millot S, El Benna J, Tourret J, Denamur E, Montravers P, Beaumont C, Lasocki S.
    Crit Care Med; 2012 Jul 08; 40(7):2141-8. PubMed ID: 22564959
    [Abstract] [Full Text] [Related]

  • 58. Safety of ferric carboxymaltose immediately after infliximab administration, in a single session, in inflammatory bowel disease patients with iron deficiency: a pilot study.
    Cortes X, Borrás-Blasco J, Molés JR, Boscá M, Cortés E.
    PLoS One; 2015 Jul 08; 10(5):e0128156. PubMed ID: 26011514
    [Abstract] [Full Text] [Related]

  • 59. Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex.
    Breymann C, von Seefried B, Stahel M, Geisser P, Canclini C.
    J Perinat Med; 2007 Jul 08; 35(2):115-8. PubMed ID: 17302514
    [Abstract] [Full Text] [Related]

  • 60. A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding.
    Schröder O, Schrott M, Blumenstein I, Jahnel J, Dignass AU, Stein J.
    Z Gastroenterol; 2004 Aug 08; 42(8):663-7. PubMed ID: 15314711
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.